Skip to content

Are you a clinical specialist involved in the diagnosis and management of patients with suspected dementia?

Photo: Designed by Freepik

Published 6 March 2025

PREDICTOM is inviting clinical specialists (aka secondary and tertiary care physicians) to complete this short survey. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.

Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation.

Take part in our survey

Latest news

🎬 PREDICTOM launches video series exploring the future of early dementia detection

News

🎬 PREDICTOM launches video series exploring the future of early dementia detection

What if Alzheimer's disease could be detected years before symptoms appear? In a newly launched nine-part video series "Predicting Dementia Before It Starts", experts from across PREDICTOM explore how advances in biomarkers, artificial intelligence, brain imaging and digital technologies, and patient involvement could enable earlier and more accurate detection of Alzheimer's disease.

Read more
🤔 How Participants Move from Level 1 to Level 2 in PREDICTOM?

News

🤔 How Participants Move from Level 1 to Level 2 in PREDICTOM?

PREDICTOM applies a risk enrichment strategy to support scalable early detection of Alzheimer’s disease while ensuring that healthcare resources are deployed where they add most value. Movement from Level 1 to Level 2 is based on predictive risk modelling using routine primary care data, enabling population wide reach combined with targeted depth.

Read more
📄 At  Home Alzheimer’s Detection Takes a Leap Forward

News

📄 At Home Alzheimer’s Detection Takes a Leap Forward

Imagine checking your brain health the way you check your blood pressure or sleep patterns—quickly, privately, and from the comfort of your own home. That vision is no longer futuristic speculation but the driving force behind PREDICTOM, a major European study that is quietly reshaping how Alzheimer’s disease might be detected long before symptoms appear.

Read more